Blog Articles
A scientific hub to keep you informed about our latest research and company updates.
![InnoSer Presents New Data on Tau[P301S] and α-Synuclein Combination Models for Neurodegenerative Research at ADPD 2025](https://www.innoserlaboratories.com/wp-content/uploads/2025/03/ADPD-2025-InnoSer-Neurodegenerative-Disease-Models-400x250.png)
InnoSer Presents New Data on Tau[P301S] and α-Synuclein Combination Models for Neurodegenerative Research at ADPD 2025
2025年に前臨床研究に組み込むべきトップ4のマルチオルガン・オン・ア・チップ TissUse アッセイとその理由
マウスデータを用いたPK/PD関係の確立による前臨床研究の推進方法
InnoSerの主要なin vitro腫瘍学サービスを探る：PD-1/PD-L1遮断アッセイ
InnoSerの臨床前てんかん研究CROプラットフォームのご紹介
The Application of Bioluminescence Imaging in Preclinical Oncology Research and Beyond
InnoSer to Present Novel Data at AD/PD 2024 Showcasing in Vitro Neurodegenerative Disease Modelling Capabilities
The Importance of Including Translational Kidney Function Readouts in Your Preclinical Research: Transdermal GFR Measurement
Translational In Vitro Assays to Screen Drug’s Efficacy for Alzheimer’s and Parkinson’s disease
Case Study: Acute Skin Inflammation Psoriasis Model
新規トランスレーショナル測定法：脆弱X症候群モデルにおける聴覚事象関連電位脳波記録
info@innoserlaboratories.com